vitamin k 3 has been researched along with Lung Injury, Acute in 1 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, S | 1 |
| Nishiumi, S | 1 |
| Nishida, M | 1 |
| Mizushina, Y | 1 |
| Kobayashi, K | 1 |
| Masuda, A | 1 |
| Fujita, T | 1 |
| Morita, Y | 1 |
| Mizuno, S | 1 |
| Kutsumi, H | 1 |
| Azuma, T | 1 |
| Yoshida, M | 1 |
1 other study available for vitamin k 3 and Lung Injury, Acute
| Article | Year |
|---|---|
Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activation.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; C | 2010 |